| Schedule of Restructuring Costs |
Restructuring and other costs were recorded in the Consolidated Statements of Operations as follows: | | | | | | | | | | | | | | | | | | | | | Three Months Ended March 31, | | | | (in millions) | | 2026 | | 2025 | | | | | | | | | | | | | | | | | | | | | | | | Selling, general, and administrative expenses | | — | | | 1 | | | | | | | Restructuring and other costs | | 67 | | | 9 | | | | | | | | | | | | | | | | Total restructuring and other costs | | $ | 67 | | | $ | 10 | | | | | |
|
| Schedule of Restructuring Accruals |
The liabilities associated with the Company’s restructuring plans are recorded in Accrued liabilities and Other noncurrent liabilities in the Consolidated Balance Sheets. Activity in the Company’s restructuring accruals at March 31, 2026 was as follows: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Severance | | (in millions) | | | | 2024 and Prior Plans | | 2026 Plan | | Other Actions | | Total | | | | | | | | | | | | | Balance at December 31, 2025 | | | | $ | 3 | | | $ | — | | | $ | 7 | | | $ | 10 | | | Provisions | | | | — | | | 59 | | | 4 | | | 63 | | | Amounts applied | | | | (1) | | | (3) | | | (2) | | | (6) | | | | | | | | | | | | | | Balance at March 31, 2026 | | | | $ | 2 | | | $ | 56 | | | $ | 9 | | | $ | 67 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | Other Restructuring Costs | | (in millions) | | 2024 and Prior Plans | | 2026 Plan | | Other Actions | | Total | | | | | | | | | | | Balance at December 31, 2025 | | $ | — | | | $ | — | | | $ | 2 | | | $ | 2 | | | Provisions | | — | | | 1 | | | 3 | | | 4 | | | Amounts applied | | — | | | — | | | (4) | | | (4) | | | | | | | | | | | | Balance at March 31, 2026 | | $ | — | | | $ | 1 | | | $ | 1 | | | $ | 2 | |
|
| Schedule of Company’s Segment Information |
The Company’s reportable segment information was as follows: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended March 31, | | | (in millions) | | 2026 | | | | | | | | | | | | | | | | | | | | Connected Technology Solutions | | Essential Dental Solutions | | Orthodontic and Implant Solutions | | Wellspect Healthcare | | Total | | | | | | | | | | | | | | | | | | | Net sales | | $ | 246 | | | $ | 350 | | | $ | 199 | | | $ | 85 | | | $ | 880 | | | | | | | | | | | | | | | | | | | Adjusted cost of products sold (a) | | 156 | | | 132 | | | 104 | | | 37 | | | | | | | Adjusted selling expenses (b) | | 53 | | | 69 | | | 54 | | | 14 | | | | | | | Adjusted general and administrative (“G&A”) expenses (b) | | 23 | | | 20 | | | 21 | | | 8 | | | | | | | Adjusted research and development (“R&D”) expenses (c) | | 20 | | | 8 | | | 12 | | | 3 | | | | | | | | | | | | | | | | | | | | | | Segment adjusted operating income | | $ | (6) | | | $ | 121 | | | $ | 8 | | | $ | 23 | | | $ | 146 | | | | | | | | | | | | | | | | | | | | Reconciling items (income) expense: | | | | | | | | | | | | | | Unallocated corporate costs (d) | | | | | | | | | | $ | 72 | | | | | | Interest expense, net | | | | | | | | | | 24 | | | | | | Other income | | | | | | | | | | (17) | | | | | | Goodwill and intangible asset impairments | | | | | | | | | | — | | | | | | Restructuring and other costs | | | | | | | | | | 67 | | | | | | Amortization of intangibles | | | | | | | | | | 42 | | | | | | Depreciation resulting from the fair value step-up of property, plant, and equipment from business combinations | | | | | | | | | | — | | | | | | Loss before income taxes | | | | | | | | | | $ | (42) | | | | |
| | | | (a) Adjusted cost of products sold represents expenses adjusted to exclude intangible amortization expense, step-up depreciation expense, and other restructuring costs. | (b) Adjusted selling and adjusted G&A expenses represent expenses adjusted to exclude intangible amortization expense, other acquisition costs, step-up depreciation expense, and other restructuring costs. | (c) Adjusted R&D expenses represent expenses adjusted to exclude other restructuring costs. | (d) Unallocated corporate costs consist of general corporate expenses including corporate headcount costs, depreciation and amortization, certain professional service fees, and other operating costs which are not assigned to a specific segment. |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended March 31, | | (in millions) | | 2025 | | | | | | | | | | | | | | Connected Technology Solutions | | Essential Dental Solutions | | Orthodontic and Implant Solutions | | Wellspect Healthcare | | Total | | | | | | | | | | | | | Net sales | | $ | 235 | | | $ | 353 | | | $ | 217 | | | $ | 74 | | | $ | 879 | | | | | | | | | | | | | Adjusted cost of products sold (a) | | 135 | | | 124 | | | 93 | | | 27 | | | | Adjusted selling expenses (b) | | 57 | | | 71 | | | 54 | | | 13 | | | | Adjusted G&A expenses (b) | | 19 | | | 18 | | | 22 | | | 6 | | | | Adjusted R&D expenses (c) | | 17 | | | 5 | | | 11 | | | 2 | | | | | | | | | | | | | | | | Segment adjusted operating income | | $ | 7 | | | $ | 135 | | | $ | 37 | | | $ | 26 | | | $ | 205 | | | | | | | | | | | | | | Reconciling items (income) expense: | | | | | | | | | | | Unallocated corporate costs (d) | | | | | | | | | | $ | 87 | | | Interest expense, net | | | | | | | | | | 19 | | | | | | | | | | | | | | | | | | | | | | | | | Restructuring and other costs | | | | | | | | | | 9 | | | Amortization of intangibles | | | | | | | | | | 45 | | | Depreciation resulting from the fair value step-up of property, plant, and equipment from business combinations | | | | | | | | | | 1 | | | Income before income taxes | | | | | | | | | | $ | 44 | |
| | | | (a) Adjusted cost of products sold represents expenses adjusted to exclude intangible amortization expense, step-up depreciation expense, and other restructuring costs. | (b) Adjusted selling and adjusted G&A expenses represent expenses adjusted to exclude intangible amortization expense, other acquisition costs, step-up depreciation expense, and other restructuring costs. | (c) Adjusted R&D expenses represent expenses adjusted to exclude other restructuring costs. | (d) Unallocated corporate costs consist of general corporate expenses including corporate headcount costs, depreciation and amortization, certain professional service fees, and other operating costs which are not assigned to a specific segment. |
Depreciation and Amortization | | | | | | | | | | | | | | | | | | | | | Three Months Ended March 31, | | | | (in millions) | | 2026 | | 2025 | | | | | | | | | | | | | | | Connected Technology Solutions | | $ | 37 | | | $ | 43 | | | | | | | Essential Dental Solutions | | 8 | | 9 | | | | | | | Orthodontic and Implant Solutions | | 23 | | 19 | | | | | | | Wellspect Healthcare | | 5 | | 2 | | | | | | | All other (a) | | 6 | | 6 | | | | | | | Total | | $ | 79 | | | $ | 79 | | | | | |
(a) Includes unallocated corporate costs for depreciation and amortization. The cumulative amounts for the provisions and adjustments and amounts applied for all the plans by segment were as follows: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | (in millions) | | December 31, 2025 | | Provisions | | Amounts Applied | | Change in Estimates | | March 31, 2026 | | | | | | | | | | | | | Connected Technology Solutions | | $ | 1 | | | $ | 23 | | | $ | (2) | | | $ | — | | | $ | 22 | | | Essential Dental Solutions | | 4 | | | 17 | | | (3) | | | — | | | 18 | | | Orthodontic and Implant Solutions | | 3 | | | 21 | | | (4) | | | — | | | 20 | | | Wellspect Healthcare | | 2 | | | 1 | | | — | | | — | | | 3 | | | All Other | | 2 | | | 5 | | | (1) | | | — | | | 6 | | | Total | | $ | 12 | | | $ | 67 | | | $ | (10) | | | $ | — | | | $ | 69 | |
|